What is Suvoda?
Headquartered in Conshohocken, Pennsylvania, Suvoda operates at the intersection of SaaS innovation and life sciences. The company specializes in IRT systems designed to manage the intricate demands of modern clinical trials. Its platform offers highly configurable features that address the volatility of global supply chains and the precision required for patient randomization. By providing advanced reporting and customizable study design support, Suvoda enables biopharmaceutical firms to mitigate operational risks and maintain focus on patient outcomes. The company's global footprint and advisory-led service model distinguish it as a critical infrastructure provider in the drug development lifecycle.
How much funding has Suvoda raised?
Suvoda has raised a total of $40M across 1 funding round:
Private Equity
$40M
Private Equity (2019): $40M with participation from LLR
Key Investors in Suvoda
LLR
LLR Partners is a lower middle market private equity firm investing in technology and healthcare businesses, collaborating with portfolio companies to execute growth initiatives and create long-term value.
What's next for Suvoda?
With this major enterprise-level funding, Suvoda is positioned to accelerate its product roadmap and expand its global service capabilities. The strategic capital will likely be deployed to enhance the platform's interoperability with emerging digital health tools and to deepen its footprint in international markets. As clinical trials become increasingly decentralized and complex, Suvoda's focus on scalable, technology-driven solutions will be vital for maintaining its competitive edge. The firm is expected to leverage this financial backing to further refine its supply chain automation, ensuring that it remains the preferred choice for organizations navigating the high-stakes environment of clinical research.
See full Suvoda company page
